We have quite a few great team customers very good at internet marketing, QC, and dealing with kinds of troublesome trouble while in the output approach for Oxidation In Wastewater Treatment, Polyester Acrylates, Polyaluminum Chloride Coagulant, Our products have exported to North America, Europe, Japan, Korea, Australia, New Zealand, Russia and other countries. Looking forward to build up a good and long term cooperation with you in coming future!
Best-Selling Neuroleptic Treatment - 2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate – JIN DUN Detail:
2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate is used as the intermediate of Gemcitabine .
Gemcitabine is a pyrimidine nucleotide analogue, which belongs to anti metabolic anticancer drugs. It can prevent the progress of DNA synthesis in a certain period, that is, S-phase. It has the characteristics of wide anticancer spectrum, unique mechanism of action, low toxicity, no cross resistance with other chemotherapeutic drugs and no superposition of toxicity. Today, gemcitabine has been approved for use in more than 90 countries, becoming the first-line drug for the treatment of non-small cell lung cancer and the “gold standard” for the treatment of pancreatic cancer.
Product detail pictures:
Related Product Guide:
Our organization has been focusing on brand strategy. Customers' gratification is our greatest advertising. We also source OEM provider for Best-Selling Neuroleptic Treatment - 2-deoxy-2,2-difluoro-d-ribofuranose-3,5-dib enzoate – JIN DUN , The product will supply to all over the world, such as: Stuttgart, Chile, Lesotho, We care about every steps of our services, from factory selection, product development & design, price negotiation, inspection, shipping to aftermarket. Now we have implemented a strict and complete quality control system, which ensures that each product can meet quality requirements of customers. Besides, all of our solutions have been strictly inspected before shipment. Your Success, Our Glory: Our aim is to help customers realize their goals. We're making great efforts to achieve this win-win situation and sincerely welcome you to join us.